News Results
There are 369,717 News Results
Feb 28, 2019
IRVINE, Calif. and HERSTAL, Belgium, Feb. 28, 2019 /PRNewswire/ -- MDxHealth SA (Euronext: MDXH.BR), today announced its business update and financial results for the year ended December 31, 2018 and...
Feb 28, 2019
SOUTH PLAINFIELD, N.J., Feb. 28, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the fourth quarter and full year ending...
Feb 28, 2019
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today reported financial results for the fourth quarter and full year ended December 31, 2018 and...
Mar 1, 2019
-- Late breaking presentation of the Phase 2b long-term findings on the investigational molecule, bimekizumab, demonstrates complete or almost complete skin clearance in moderate-to-severe plaque psoriasis -- Long-term data from...
Mar 1, 2019
SAN RAFAEL, Calif., March 1, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the...
Mar 5, 2019
IRVINE, Calif., March 5, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported net revenue of $13.0 million and $46.2 million for the fourth...
Mar 5, 2019
TITUSVILLE, N.J., March 5, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved SPRAVATO(TM) (esketamine) CIII nasal...
Mar 6, 2019
ELKHART, Ind., March 6, 2019 /PRNewswire/ -- Thor Industries, Inc. (NYSE: THO) today announced second- quarter results with net sales of $1.29 billion, compared with the record second-quarter revenue posted...
Mar 6, 2019
NEW YORK, March 6, 2019 /PRNewswire/ -- Cannabis is steadily being adopted as a medical alternative for various applications. Primarily, consumers are using cannabis to treat a wide range of...
Mar 6, 2019
-- Q4 revenue of $28.5M and ($5.2)M Adjusted EBITDA -- Full year revenue of $96.6M and ($13.5)M Adjusted EBITDA -- $192.2M cash reserves at year-end VANCOUVER, March 6, 2019 /PRNewswire/...
